Evidence map›Paper›PMID 30889862›Full record

ArticleMolecules (Basel, Switzerland)2019

Design and Synthesis of Novel Heterocyclic-Based 4

Fawzia F Alblewi, Rawda M Okasha, Areej A Eskandrani, Tarek H Afifi, Hany M Mohamed, Ahmed H Halawa, Ahmed M Fouda, Al-Anood M Al-Dies, Ahmed Mora, Ahmed M El-Agrody

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 45 citations in OpenAlex.

  1. Benzo[ACS omega · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Development of Novel Class of Phenylpyrazolo[3,4-International journal of molecular sciences · 2023
    Article
  11. Synthesis of 9-Hydroxy-1International journal of molecular sciences · 2022
    Article
  12. A New Family of Benzo[International journal of molecular sciences · 2021
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Fawzia F AlblewiChemistry department, Faculty of Science, Taibah University, Medina 30002, Saudi Arabia. fbalawi@taibahu.edu.sa.
Rawda M OkashaChemistry department, Faculty of Science, Taibah University, Medina 30002, Saudi Arabia. rawdao@yahoo.com.
Areej A EskandraniChemistry department, Faculty of Science, Taibah University, Medina 30002, Saudi Arabia. a.eskandrani@gmail.com.
Tarek H AfifiChemistry department, Faculty of Science, Taibah University, Medina 30002, Saudi Arabia. afifith@yahoo.com.
Hany M MohamedChemistry Department, Faculty of Science, Jazan University, Jazan 2097, Saudi Arabia. hanysm83@yahoo.com.ORCID 0000-0002-9575-5435
Ahmed H HalawaChemistry Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo 11884, Egypt. ahmedhalawa_79@yahoo.com.
Ahmed M FoudaChemistry Department, Faculty of Scinece, King Khalid University, P.O. Box 9004, Abha 61413, Saudi Arabia. amfouda@hotmail.com.
Al-Anood M Al-DiesChemistry Department, Faculty of Scinece, King Khalid University, P.O. Box 9004, Abha 61413, Saudi Arabia. nood-mansyaa@hotmail.com.ORCID 0000-0003-4756-4826
Ahmed MoraChemistry Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo 11884, Egypt. autobus78@yahoo.com.
Ahmed M El-AgrodyChemistry Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo 11884, Egypt. elagrody_am@yahoo.com.ORCID 0000-0001-7019-411X
Al-Azhar University · EGTaibah University · SAKing Khalid University · SAUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel fused chromenes (

Indexed as

Drug DesignAntineoplastic AgentsApoptosisBenzopyransCaspase 3Caspase 7Caspase InhibitorsCell CycleCell Line, TumorCell MovementDNA FragmentationHeterocyclic CompoundsHumansInhibitory Concentration 50Neoplasm InvasivenessStructure-Activity RelationshipAntineoplastic AgentsBenzopyransCaspase 3Caspase 7Caspase InhibitorsHeterocyclic Compoundsand migrationcaspase 3/7 activitycell apoptosiscell cycle analysiscell invasionDNA fragmentationfused chromenes and pyrimidinesSAR

Identifiers

PMID30889862
PMCPMC6471608
OpenAlexW2921743009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.